Glaxosmithkline Pharmaceuticals Ltd logo

GLAXO

Glaxosmithkline Pharmaceuticals Ltd

₹2,677.85

Glaxosmithkline Pharmaceuticals Ltd Q4 FY2023-2024 Results: Summary

Revenue
₹962.03Cr
Net Profits
₹194.48Cr
Net Profit Margins
20.22%

Highlights

Revenue:

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 16.54% since last year same period to ₹962.03Cr in the Q4 2023-2024. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 15.44% jump in its revenue since last 3-months.

Net Profits:

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 45.75% since last year same period to ₹194.48Cr in the Q4 2023-2024. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 325.37% jump in its net profits since last 3-months.

Net Profit Margins:

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 25.07% since last year same period to 20.22% in the Q4 2023-2024. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 268.48% jump in its net profit margins since last 3-months.

FAQs

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was ₹962.03Cr.

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was ₹194.48Cr.

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was 20.22%.

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2022 was ₹825.51Cr.

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2022 was ₹133.43Cr.

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2022 was 16.16%.